Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farnaz Zahedifard

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Immunology Letters|October 23, 2012
Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice modelAmin Daemi, Azam Bolhassani, Sima Rafati, et al.
Experimental Parasitology|February 13, 2021
Evaluation of protection induced by in vitro maturated BMDCs presenting CD8<sup>+</sup> T cell stimulating peptides after a heterologous vaccination regimen in BALB/c model against Leishmania majorAtefeh Sadeghi Shermeh, Farnaz Zahedifard, Sima Habibzadeh, et al.
Vaccine|September 23, 2008
Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individualsNaghmeh Khoshgoo, Farnaz Zahedifard, Hiva Azizi, et al.
Experimental Parasitology|April 27, 2010
Leishmania major: disruption of signal peptidase type I and its consequences on survival, growth and infectivityTahereh Taheri, Ali-Hatef Salmanian, Elham Gholami, et al.
Plos Neglected Tropical Diseases|July 17, 2019
Correction: Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentialsFarnaz Zahedifard, Hyeryon Lee, Joo Hwan No, et al.
Journal of Biotechnology|March 7, 2006
Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergyNariman Aghaei Bandbon Balenga, Farnaz Zahedifard, Richard Weiss, et al.
The Journal of Biological Chemistry|September 13, 2025
The trypanosome vault particle is composed of multiple major vault protein paralogs and harbors vault RNAAnna Zavrelova, Siqi Shen, Farnaz Zahedifard, et al.
Vaccines|October 27, 2022
Antibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA VectorsNegar Seyed, Farnaz Zahedifard, Sima Habibzadeh, et al.
Iranian Journal of Parasitology|October 21, 2020
Comparison of Protective Potency of DNA and Live Vaccines Expressing A2-CPA-CPB<sup>-CTE</sup> Antigens against Visceral Leishmaniasis in Syrian Hamster as Preliminary StudyYasaman Taslimi, Farnaz Zahedifard, Tahereh Taheri, et al.
Plos Neglected Tropical Diseases|February 28, 2019
Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentialsFarnaz Zahedifard, Hyeryon Lee, Joo Hwan No, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Immunology Letters|October 23, 2012
Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice modelAmin Daemi, Azam Bolhassani, Sima Rafati, et al.
Experimental Parasitology|February 13, 2021
Evaluation of protection induced by in vitro maturated BMDCs presenting CD8<sup>+</sup> T cell stimulating peptides after a heterologous vaccination regimen in BALB/c model against Leishmania majorAtefeh Sadeghi Shermeh, Farnaz Zahedifard, Sima Habibzadeh, et al.
Vaccine|September 23, 2008
Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individualsNaghmeh Khoshgoo, Farnaz Zahedifard, Hiva Azizi, et al.
Experimental Parasitology|April 27, 2010
Leishmania major: disruption of signal peptidase type I and its consequences on survival, growth and infectivityTahereh Taheri, Ali-Hatef Salmanian, Elham Gholami, et al.
Plos Neglected Tropical Diseases|July 17, 2019
Correction: Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentialsFarnaz Zahedifard, Hyeryon Lee, Joo Hwan No, et al.
Journal of Biotechnology|March 7, 2006
Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergyNariman Aghaei Bandbon Balenga, Farnaz Zahedifard, Richard Weiss, et al.
The Journal of Biological Chemistry|September 13, 2025
The trypanosome vault particle is composed of multiple major vault protein paralogs and harbors vault RNAAnna Zavrelova, Siqi Shen, Farnaz Zahedifard, et al.
Vaccines|October 27, 2022
Antibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA VectorsNegar Seyed, Farnaz Zahedifard, Sima Habibzadeh, et al.
Iranian Journal of Parasitology|October 21, 2020
Comparison of Protective Potency of DNA and Live Vaccines Expressing A2-CPA-CPB<sup>-CTE</sup> Antigens against Visceral Leishmaniasis in Syrian Hamster as Preliminary StudyYasaman Taslimi, Farnaz Zahedifard, Tahereh Taheri, et al.
Plos Neglected Tropical Diseases|February 28, 2019
Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentialsFarnaz Zahedifard, Hyeryon Lee, Joo Hwan No, et al.
Pageof 5